Literature DB >> 1149809

Permanent bile duct cannulation in the monkey. A model for studying intestinal absorption.

J Meszaros, F Nimmerfall, J Rosenthaler, H Weber.   

Abstract

Our aim has been to obtain an experimental model where the test animal is subjected to the least amount of stress and restraint, and can serve for the repeated sampling of biliary excretion over a prolonged period of time. By using a special end-piece at the outer terminals of the two cannulas the monkeys could be given full freedom after experimentation. During the course of the study it was found that insertion of the cannula into the common bile duct led to the development of collateral pathways for passage of bile around the point of insertion. This adaption reaction for the restoration of a normal bile channel would seem to be characteristic of Rhesus monkeys, for we did not encounter it in similar experiments on dogs and minipigs. The experimental model described is intended to serve for the determination of intestinal absorption of compounds that are mainly excreted via the bile. Results with radioactive ergotamine are presented.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149809     DOI: 10.1016/0014-2999(75)90288-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine.

Authors:  F Nimmerfall; J Rosenthaler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

2.  Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.

Authors:  G Maurer; E Schreier; S Delaborde; R Nufer; A P Shukla
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

3.  Ergovaline toxicity on Caco-2 cells as assessed by MTT, alamarBlue, and DNA assays.

Authors:  Nancy W Shappell
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.